ArticleFrontiers in immunology2026

AKNA serves as a prognostic biomarker and restrains endometrial cancer progression via STING activation and macrophage reprogramming.

Yuan Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.